abstract |
Combination of erythropoietin glycoisoforms, wherein said glycoisoforms may comprise an amount of sialic acid of between 4 to 10 sialic acid molecules per molecule of erythropoietin, the combination of glycoisoforms can be used for the treatment or prevention of septicemia / sepsis, a pharmaceutical composition comprising said combination, a cell line producing a combination of erythropoietin glycosoforms, procedures for obtaining the cell line, procedures for obtaining the cell line, procedure for producing said combination of glycoisoforms and methods of treatment and prevention of septicemia / sepsis |